- Home
- RCUS vs FLNG Comparison
RCUS vs FLNG Comparison
Compare RCUS & FLNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCUS
- FLNG
- Stock Information
- Founded
- RCUS 2015
- FLNG 2006
- Country
- RCUS United States
- FLNG Bermuda
- Employees
- RCUS N/A
- FLNG N/A
- Industry
- RCUS Biotechnology: Pharmaceutical Preparations
- FLNG Marine Transportation
- Sector
- RCUS Health Care
- FLNG Consumer Discretionary
- Exchange
- RCUS Nasdaq
- FLNG Nasdaq
- Market Cap
- RCUS 1.2B
- FLNG 1.3B
- IPO Year
- RCUS 2018
- FLNG N/A
- Fundamental
- Price
- RCUS $11.07
- FLNG $23.30
- Analyst Decision
- RCUS Buy
- FLNG Hold
- Analyst Count
- RCUS 11
- FLNG 1
- Target Price
- RCUS $31.11
- FLNG $23.00
- AVG Volume (30 Days)
- RCUS 1.1M
- FLNG 484.5K
- Earning Date
- RCUS 02-25-2025
- FLNG 02-04-2025
- Dividend Yield
- RCUS N/A
- FLNG 12.89%
- EPS Growth
- RCUS N/A
- FLNG N/A
- EPS
- RCUS N/A
- FLNG 2.18
- Revenue
- RCUS $263,000,000.00
- FLNG $356,349,000.00
- Revenue This Year
- RCUS $127.65
- FLNG N/A
- Revenue Next Year
- RCUS N/A
- FLNG $3.58
- P/E Ratio
- RCUS N/A
- FLNG $10.51
- Revenue Growth
- RCUS 119.17
- FLNG N/A
- 52 Week Low
- RCUS $10.63
- FLNG $20.85
- 52 Week High
- RCUS $20.31
- FLNG $30.48
- Technical
- Relative Strength Index (RSI)
- RCUS 34.34
- FLNG 39.21
- Support Level
- RCUS $10.63
- FLNG $23.73
- Resistance Level
- RCUS $13.49
- FLNG $24.81
- Average True Range (ATR)
- RCUS 0.77
- FLNG 0.66
- MACD
- RCUS -0.13
- FLNG -0.31
- Stochastic Oscillator
- RCUS 13.88
- FLNG 13.48
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About FLNG FLEX LNG Ltd.
Flex LNG Ltd is an LNG shipping company with a fleet of next-generation LNG carriers with large cargo capacity. The fleet consists of thirteen modern LNG ships, ten existing and three under construction for delivery. All LNG carriers are equipped with slow-speed, two-stroke engines MEGI or X-DF propulsion which will provide Charterers with state-of-the-art tonnage offering significant advantages in form of reduced fuel consumption and lowered boil-off rates.